How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease—decision analysis and comparison of three international patient populations

BACKGROUND: We recently developed a clinical decision support tool, capable of estimating the likelihood of survival at 3 and 12 months following surgery for patients with operable skeletal metastases. After making it publicly available on www.PATHFx.org, we attempted to externally validate it using...

Descripción completa

Detalles Bibliográficos
Autores principales: Piccioli, Andrea, Spinelli, M. Silvia, Forsberg, Jonathan A., Wedin, Rikard, Healey, John H., Ippolito, Vincenzo, Daolio, Primo Andrea, Ruggieri, Pietro, Maccauro, Giulio, Gasbarrini, Alessandro, Biagini, Roberto, Piana, Raimondo, Fazioli, Flavio, Luzzati, Alessandro, Di Martino, Alberto, Nicolosi, Francesco, Camnasio, Francesco, Rosa, Michele Attilio, Campanacci, Domenico Andrea, Denaro, Vincenzo, Capanna, Rodolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443666/
https://www.ncbi.nlm.nih.gov/pubmed/25998535
http://dx.doi.org/10.1186/s12885-015-1396-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443666/
https://www.ncbi.nlm.nih.gov/pubmed/25998535
http://dx.doi.org/10.1186/s12885-015-1396-5

Ejemplares similares